Regular
NAV (18-Jun-25)
Returns (Since Inception)
Fund Overview
Fund Size
₹2,242 Cr
Expense Ratio
1.99%
ISIN
INF174KA1TJ3
Minimum SIP
₹100
Exit Load
No Charges
Inception Date
28 Oct 2024
About this fund
As of 18-Jun-25, it has a Net Asset Value (NAV) of ₹9.91, Assets Under Management (AUM) of 2241.81 Crores, and an expense ratio of 1.99%.
- Kotak MNC Fund Regular Growth has given a CAGR return of -0.85% since inception.
- The fund's asset allocation comprises around 95.50% in equities, 0.00% in debts, and 4.50% in cash & cash equivalents.
- You can start investing in Kotak MNC Fund Regular Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.
Performance against Category Average
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
Since Inception
-0.85%
— (Cat Avg.)
Portfolio Summaryas of 31st May 2025
| Equity | ₹2,140.94 Cr | 95.50% |
| Others | ₹100.87 Cr | 4.50% |
Top Holdings
All Holdings
Equity
Debt & Others
| Name | Type  | Amount | Holdings |
|---|---|---|---|
| Maruti Suzuki India Ltd | Equity | ₹190.94 Cr | 8.52% |
| Hindustan Unilever Ltd | Equity | ₹164.38 Cr | 7.33% |
| Britannia Industries Ltd | Equity | ₹142.28 Cr | 6.35% |
| Triparty Repo | Cash - Repurchase Agreement | ₹105.78 Cr | 4.72% |
| United Spirits Ltd | Equity | ₹93.08 Cr | 4.15% |
| Nestle India Ltd | Equity | ₹82.05 Cr | 3.66% |
| Bharti Airtel Ltd | Equity | ₹64.97 Cr | 2.90% |
| J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹62.02 Cr | 2.77% |
| Oracle Financial Services Software Ltd | Equity | ₹60.51 Cr | 2.70% |
| Azad Engineering Ltd | Equity | ₹60.04 Cr | 2.68% |
| Tech Mahindra Ltd | Equity | ₹55.09 Cr | 2.46% |
| Marksans Pharma Ltd | Equity | ₹52.28 Cr | 2.33% |
| Sun Pharmaceuticals Industries Ltd | Equity | ₹49.82 Cr | 2.22% |
| Schaeffler India Ltd | Equity | ₹49.39 Cr | 2.20% |
| Tata Chemicals Ltd | Equity | ₹48.22 Cr | 2.15% |
| GE Vernova T&D India Ltd | Equity | ₹47.7 Cr | 2.13% |
| Acutaas Chemicals Ltd | Equity | ₹46.98 Cr | 2.10% |
| Nippon Life India Asset Management Ltd Ordinary Shares | Equity | ₹45.64 Cr | 2.04% |
| Swiggy Ltd | Equity | ₹44.76 Cr | 2.00% |
| ABB India Ltd | Equity | ₹44.01 Cr | 1.96% |
| Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹43.07 Cr | 1.92% |
| Ashok Leyland Ltd | Equity | ₹42.96 Cr | 1.92% |
| Jubilant Pharmova Ltd | Equity | ₹42.49 Cr | 1.90% |
| Glenmark Pharmaceuticals Ltd | Equity | ₹41.8 Cr | 1.86% |
| Timken India Ltd | Equity | ₹41.68 Cr | 1.86% |
| Siemens Ltd | Equity | ₹40.36 Cr | 1.80% |
| Cummins India Ltd | Equity | ₹36.54 Cr | 1.63% |
| Fortis Healthcare Ltd | Equity | ₹35.66 Cr | 1.59% |
| Infosys Ltd | Equity | ₹34.38 Cr | 1.53% |
| Mphasis Ltd | Equity | ₹33.26 Cr | 1.48% |
| Grindwell Norton Ltd | Equity | ₹32.76 Cr | 1.46% |
| CRISIL Ltd | Equity | ₹31.87 Cr | 1.42% |
| Siemens Engy Ind | Equity | ₹30.63 Cr | 1.37% |
| ZF Commercial Vehicle Control Systems India Ltd | Equity | ₹30.08 Cr | 1.34% |
| Bosch Ltd | Equity | ₹29.26 Cr | 1.31% |
| MTAR Technologies Ltd | Equity | ₹28.68 Cr | 1.28% |
| Colgate-Palmolive (India) Ltd | Equity | ₹28.24 Cr | 1.26% |
| Tega Industries Ltd | Equity | ₹26.58 Cr | 1.19% |
| KSB Ltd | Equity | ₹20.56 Cr | 0.92% |
| Samvardhana Motherson International Ltd | Equity | ₹19.82 Cr | 0.88% |
| Vedanta Ltd | Equity | ₹17.42 Cr | 0.78% |
| Sona BLW Precision Forgings Ltd | Equity | ₹16.59 Cr | 0.74% |
| Orchid Pharma Ltd | Equity | ₹11.65 Cr | 0.52% |
| Gland Pharma Ltd | Equity | ₹7.3 Cr | 0.33% |
| Juniper Hotels Ltd | Equity | ₹7 Cr | 0.31% |
| Sai Life Sciences Ltd | Equity | ₹5.3 Cr | 0.24% |
| Net Current Assets/(Liabilities) | Cash | ₹-4.91 Cr | 0.22% |
| Ambuja Cements Ltd | Equity | ₹0.83 Cr | 0.04% |
Allocation By Market Cap (Equity)
Large Cap Stocks
49.51%
Mid Cap Stocks
19.34%
Small Cap Stocks
25.28%
Other Allocation
Equity Sector
Debt & Others
| Sector | Amount | Holdings |
|---|---|---|
| Consumer Defensive | ₹510.03 Cr | 22.75% |
| Industrials | ₹421.88 Cr | 18.82% |
| Consumer Cyclical | ₹387.83 Cr | 17.30% |
| Healthcare | ₹351.4 Cr | 15.68% |
| Technology | ₹183.24 Cr | 8.17% |
| Basic Materials | ₹113.45 Cr | 5.06% |
| Financial Services | ₹77.51 Cr | 3.46% |
| Communication Services | ₹64.97 Cr | 2.90% |
Risk & Performance Ratios
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Fund Managers
Harsha Upadhyaya
Since October 2024
Abhishek Bisen
Since October 2024
Dhananjay Tikariha
Since October 2024
Additional Scheme Detailsas of 31st May 2025
ISIN | INF174KA1TJ3 | Expense Ratio | 1.99% | Exit Load | No Charges | Fund Size | ₹2,242 Cr | Age | 7 months | Lumpsum Minimum | ₹100 | Fund Status | Open Ended Investment Company | Benchmark | Nifty MNC TR INR |
Investment Objective
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Tax Treatment
Capital Gains Taxation:
- If units are sold after 1 year from the date of investment: Gains up to INR 1.25 lakh in a financial year are exempt from tax. Any gains exceeding INR 1.25 lakh are taxed at a rate of 12.5%.
- If units are sold within 1 year from the date of investment: The entire amount of gain is taxed at a rate of 20%.
- Holding the units: No tax is applicable as long as you continue to hold the units.
Dividend Taxation:
Dividends are added to the investor’s income and taxed according to their respective tax slabs. Additionally, if an investors dividend income exceeds INR 5,000 in a financial year, the fund house deducts a 10% Tax Deducted at Source (TDS) before distributing the dividend.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Similar Equity - Other Funds
| Fund name | Expense Ratio | Exit Load | Fund size | 1Y  |
|---|---|---|---|---|
| Motilal Oswal Nifty India Tourism ETF Very High Risk | - | - | - | - |
| Motilal Oswal Nifty India Manufacturing ETF Very High Risk | - | - | ₹5.27 Cr | - |
| Motilal Oswal Services Fund Direct Growth Very High Risk | - | 1.0% | - | - |
| Motilal Oswal Services Fund Regular Growth Very High Risk | - | 1.0% | - | - |
| ICICI Prudential Quality Fund Direct Growth Very High Risk | - | 1.0% | ₹1801.45 Cr | - |
| ICICI Prudential Quality Fund Regular Growth Very High Risk | - | 1.0% | ₹1801.45 Cr | - |
| Motilal Oswal Nifty Capital Market ETF Very High Risk | 0.3% | - | ₹4.63 Cr | - |
| Mirae Asset BSE Select IPO ETF Very High Risk | 0.2% | - | ₹18.06 Cr | - |
| Mirae Asset BSE Select IPO ETF Fund of Fund Regular Growth Very High Risk | 0.9% | 0.0% | ₹9.66 Cr | - |
| Mirae Asset BSE Select IPO ETF Fund of Fund Direct Growth Very High Risk | 0.2% | 0.0% | ₹9.66 Cr | - |
Risk Level
Your principal amount will be at Very High Risk
Unlock Expert Insights!
Related Articles
Still got questions?
We're here to help.
What is the current NAV of Kotak MNC Fund Regular Growth?
What is the portfolio composition of Kotak MNC Fund Regular Growth?
Who manages the Kotak MNC Fund Regular Growth?
- Harsha Upadhyaya
- Abhishek Bisen
- Dhananjay Tikariha
Dezerv Investments Private Limited is a Portfolio Manager with SEBI Registration no. INP000007377 and an Investment Manager to Category - I AIF-VCF-Angel Fund with SEBI Registration no. IN/AIF1/22-23/1066.
Mutual Fund distribution services are offered through Dezerv Distribution Services Pvt Limited, a wholly owned subsidiary with AMFI Registration No.: ARN -248439. **Mutual fund investments are subject to market risks, read all scheme related documents carefully.** Terms and conditions of the website are applicable. Privacy policy of the website is applicable.